OSL 0.00% 0.8¢ oncosil medical ltd

Ann: FDA Grants Breakthrough Device Designation, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,071 Posts.
    lightbulb Created with Sketch. 179
    great work OSL!!! achieving a great milstone into US market. OncoSil Medical receives FDA Breakthrough Device Designation for its device for the treatment of unresectable locally advanced pancreatic cancer in combination with systemic chemotherapy.
    next step is now to work closely with the FDA to ensure that the proposed premarket approval PMA
 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $35.79M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $15.08K 1.896M

Buyers (Bids)

No. Vol. Price($)
60 26812666 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 9806935 4
View Market Depth
Last trade - 13.15pm 08/11/2024 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.